High-resolution Continuum Source Aas ? Redefining Aas

Laboratory products

High-resolution Continuum Source Aas ? Redefining Aas

28 Mar, 2006

Published over 20 years ago. See the latest and most current information on Laboratory products.

contrAA is the newest generation of flame AA spectrometer, from Analytik Jena AG, featuring highest performance and never seen dimensions in flame analysis never change lamps again.

The contrAA atomic absorption spectrometer is the first commercially available instrument for the HR-CS AAS with impressively unique features:

? Immediately ready to measure, no lamp drift because of simultaneous double beam stability
? Simple operation and simple and rapid method development (free of interferences)
? Low running cost
? High sample throughput
? Ready to measure for each element on each line (rare elements, PO-, CS-bands)
? Real sequential multi element analysis, partly simultaneous determination of trace minor and major elements (Ni/Fe, CU/Ni, Pb/Fe)
? Improved detection limits
? Improved simultaneous background correction (spectral interferences, molecular flame structures) with CCD-Detector

The contrAA is characterized by robustness, capability of determining a wide range of elements in complex waste and waste waters with low operational costs and performance similar to competitive techniques such as the inductively coupled plasma (ICP). Thus this approach closes the gap between AAS and ICP and is a viable alternative procedure.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
World Bank commits USD600m to clean air programmes in Uttar Pradesh and Haryana
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow